| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| ABVX | Abivax S.A. | 0.50% | 875,796 | $74,355,080 | 875,796 | New | $84.9 | 13F |
| CELC | Celcuity Inc. (PRN) | 0.27% | 30,750,000 | $40,905,126 | 30,750,000 | New | $1.33 | 13F |
| IONS | Ionis Pharmaceuticals, Inc. | 0.25% | 566,798 | $37,079,925 | 566,798 | New | $65.42 | 13F |
| RNA | Avidity Biosciences, Inc. | 0.18% | 625,000 | $27,231,250 | 625,000 | New | $43.57 | 13F |
| VKTX | Viking Therapeutics, Inc. | 0.06% | 366,083 | $9,620,661 | 366,083 | New | $26.28 | 13F |
| PHVS | Pharvaris N.V. | 0.06% | 375,000 | $9,356,250 | 375,000 | New | $24.95 | 13F |
| HRTX | Heron Therapeutics, Inc. | 0.04% | 4,251,951 | $5,357,458 | 4,251,951 | New | $1.26 | 13F |
| MBX | MBX Biosciences, Inc. | 0.03% | 277,777 | $4,861,098 | 277,777 | New | $17.5 | 13F |
| LBRX | LB Pharmaceuticals Inc. | 0.02% | 200,000 | $3,158,000 | 200,000 | New | $15.79 | 13F |
| VTYX | Ventyx Biosciences, Inc. | 0.02% | 1,023,130 | $3,181,934 | 1,023,130 | New | $3.11 | 13F |
| GBIO | Generation Bio Co. | 0.00798% | 194,493 | $1,190,297 | 194,493 | New | $6.12 | 13F |
| VYNE | VYNE Therapeutics Inc. | 0.00191% | 851,353 | $285,203 | 851,353 | New | $0.33 | 13F |